Epstein-Barr Virus Antibody to Viral Capsid Antigen, IgA
0051626
Ordering Recommendation
Do not use to diagnose Epstein-Barr virus infectious mononucleosis. May aid in the detection and prognosis of nasopharyngeal carcinoma.
Mnemonic
EBV A
Methodology
Semi-Quantitative Enzyme-Linked Immunosorbent Assay
Performed
Tue
Reported
1-8 days  
New York DOH Approval Status
This test is New York DOH approved.
Submit With Order
Specimen Required
Patient Preparation
  
Collect
Serum separator tube.  
Specimen Preparation
Separate serum from cells ASAP or within 2 hours of collection. Transfer 0.5 mL serum to an ARUP Standard Transport Tube. (Min: 0.1 mL) Parallel testing is preferred and convalescent specimens must be received within 30 days from receipt of the acute specimens. Mark specimen plainly as "acute" or "convalescent."  
Storage/Transport Temperature
Refrigerated.  
Unacceptable Conditions
Contaminated or heat-inactivated specimens.  
Remarks
  
Stability
After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year  
Reference Interval
Effective February 19, 2013

0.79 U/mL or less:  Not Detected
0.80 - 1.20 U/mL: Indeterminate.  Repeat testing in 10-14 days may be helpful.
1.21 U/mL or greater:  Detected  
Interpretive Data


See Compliance Statement D: www.aruplab.com/CS  
Note
 
CPT Code(s)
86665
Components
Component Test Code*Component Chart Name
0051626EBV Antibody To Viral Capsid Antigen IgA
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • EBV Antibodies
  • EBV VCA-IgA Ab
  • Infectious Mononucleosis